Digital Marketing Trends in Inflammatory Bowel Disease

Pages: 36 Published: March 31, 2022 Report Code: GDHCHT317

The digital marketing trends in inflammatory bowel disease report analyses key digital marketing metrics of pharma assets in inflammatory bowel disease (IBD), including branded websites for patients and healthcare professionals (HCPs), mobile apps, and social media accounts.

What are the major US patient branded websites of bowel disease?

The major US patient branded websites of Bowel disease are AbbVie’s Humira.com, Takeda’s Entyvio.com, Pfizer’s Xeljanz.com, Janssen’s Stelarainfo.com, Janssen’s Remicade.com, UCB’s Cimzia.com, and Janssen’s Simponi.com. AbbVie achieved the highest total traffic across IBD patient sites in the US for its Humira.com.

Bowel disease digital marketing trends, by US patient branded websites

Bowel disease digital marketing trends, by US patient branded websites

For more US patient branded website insights, download a free sample

What are the major US HCP branded websites of bowel disease?

The major US HCP branded websites of bowel disease are Stelarahcp.com, Entyviohcp.com, Humirapro.com, Cimziahcp.com, and Remicadehcp.com. Humirapro.com had the highest number of total visitors among top IBD websites for HCPs in the US.

Bowel disease digital marketing trends, by US HCP branded websites

Bowel disease digital marketing trends, by US HCP branded websites

For more major US HCP branded website insights, download a free sample

What are the major EUCAN patient and HCP branded websites of bowel disease?

The major EUCAN patient and HCP branded websites of bowel disease are Abbviecare.es, Abbvie-care.de, Abbviecare.ca, Abbviecare.fr, and Takeda-gastroenterologie.de. Abbvie-care.es had the highest pages per visit, while AbbViecare.ca had the lowest bounce rate.

Bowel disease digital marketing trends, by EUCAN patient and HCP branded websites

Bowel disease digital marketing trends, by EUCAN patient and HCP branded websites

For more major EUCAN patient and HCP branded website insights, download a free sample

Who are the key digital marketing players in the inflammatory bowel disease market?

The key digital marketing players in the inflammatory bowel disease market are AbbVie, Janssen, UCB, Pfizer, Takeda, and Merck & Co. AbbVie’s Humira.com achieved the highest total traffic across inflammatory bowel disease (IBD) patient sites in the US, followed by followed by Pfizer’s Xeljanz.com and Janssen’s Stelarainfo.com.

Market overview

Major US patient branded websites AbbVie’s Humira.com, Takeda’s Entyvio.com, Pfizer’s Xeljanz.com, Janssen’s Stelarainfo.com, Janssen’s Remicade.com, UCB’s Cimzia.com, and Janssen’s Simponi.com
Major EUCAN patient and hcp branded websites Abbviecare.es, Abbvie-care.de, Abbviecare.ca, Abbviecare.fr, and Takeda-gastroenterologie.de
Major US HCP branded websites Stelarahcp.com, Entyviohcp.com, Humirapro.com, Cimziahcp.com, and Remicadehcp.com
Key digital marketing players AbbVie, Janssen, UCB, Pfizer, Takeda, and Merck & Co

Scope

  • This report assesses key digital marketing metrics of pharma assets in inflammatory bowel disease (IBD), including branded websites for patients and healthcare professionals (HCPs), mobile apps, and social media accounts.
  • Metrics include website traffic volume, engagement, and source, digital display advertising (DDA), paid search engine optimization (SEO), mobile app downloads, and social media post interaction.
  • Countries include the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).

Reasons to Buy

  • Understand the digital marketing competitive landscape in IBD, with a view of leading patient and HCP branded assets across different regions.
  • See what tactics pharma companies are using to drive traffic to their IBD branded assets for patient and HCPs, such as DDA and paid SEO.
  • Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches.
  • Compare top branded assets for patients y how they address and support different patient needs.
  • See what pharma social media accounts in IBD are the most active and achieving the most engagement.
  • See leading mobile app offerings in IBD from pharma across different regions.

Key Players

  • AbbVie

  • Janssen
  • UCB
  • Pfizer
  • Takeda
  • Merck & Co

Table of Contents

Executive Summary

US Patient Branded Websites

US HCP Branded Websites

US Digital Display Advertising and Search Engine Optimization

US Mobile Apps and Social Media

EUCAN Branded Websites

EUCAN Mobile Apps and Social Media

Appendix

Methodology

About the Authors

Contact Us

Frequently Asked Questions

$1950

Can be used by individual purchaser only

$3900

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.